HomeRVV • CNSX
add
Revive Therapeutics Ltd
Previous close
$0.015
Day range
$0.015 - $0.015
Year range
$0.0050 - $0.035
Market cap
4.71M CAD
Avg Volume
342.28K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 220.13K | -59.59% |
Net income | -281.75K | 40.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -220.08K | 59.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.95K | -92.33% |
Total assets | 249.81K | -97.51% |
Total liabilities | 3.75M | 14.05% |
Total equity | -3.50M | — |
Shares outstanding | 435.68M | — |
Price to book | -1.50 | — |
Return on assets | -241.99% | — |
Return on capital | 16.13% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -281.75K | 40.37% |
Cash from operations | -142.41K | 69.70% |
Cash from investing | — | — |
Cash from financing | 148.80K | — |
Net change in cash | 6.39K | 101.28% |
Free cash flow | -781.00 | 99.75% |
About
Founded
2012
Headquarters
Website
